恒华科技(300365) - 2024 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2024 was CNY 112,352,802.19, representing a 1.36% increase compared to CNY 110,842,853.62 in the same period last year[4] - Net profit attributable to shareholders decreased by 28.73% to CNY 2,248,608.71 from CNY 3,155,129.21 year-on-year[4] - Basic and diluted earnings per share fell by 30.19% to CNY 0.0037 from CNY 0.0053 in the same period last year[4] - Net profit for Q1 2024 was CNY 2,597,177.03, compared to CNY 1,224,721.36 in Q1 2023, indicating a significant increase of approximately 112.5%[22] - Other comprehensive income after tax for Q1 2024 was CNY 3,039,297.25, compared to CNY 9,111,267.87 in the previous year, indicating a decrease of about 66.7%[22] Cash Flow - The net cash flow from operating activities was negative at CNY -342,994,124.00, a decline of 125.89% compared to CNY -151,839,315.39 in the previous year[4] - Total cash inflow from operating activities was 128,179,913.07 CNY, down from 162,503,883.85 CNY, reflecting a decrease of approximately 21%[24] - Cash outflow from operating activities increased to 471,174,037.07 CNY, compared to 314,343,199.24 CNY, representing a rise of about 50%[24] - The net cash flow from investing activities was 100,969,715.71 CNY, a turnaround from -2,126,469.32 CNY in the previous period[26] - Cash inflow from investing activities totaled 101,433,604.99 CNY, significantly higher than 162,675.00 CNY previously[26] - Cash outflow from investing activities decreased to 463,889.28 CNY from 2,289,144.32 CNY, showing a reduction of approximately 80%[26] - The net cash flow from financing activities was -77,786,890.24 CNY, compared to a positive 97,883,270.54 CNY in the previous period[26] - The total cash and cash equivalents at the end of the period were 418,063,607.17 CNY, up from 324,135,633.47 CNY[26] - The company reported a cash inflow from other investment-related activities of 100,000,000.00 CNY[26] - The company's cash flow from operating activities indicates a need for strategic adjustments to improve financial health[24] Assets and Liabilities - Total assets decreased by 3.94% to CNY 2,413,063,321.06 from CNY 2,511,976,720.46 at the end of the previous year[4] - Total current assets decreased to approximately ¥2.06 billion from ¥2.15 billion, a decline of about 4.5%[17] - Total liabilities decreased to CNY 338,379,332.24 from CNY 442,929,205.92, a reduction of about 23.6%[19] - The company's equity attributable to shareholders increased to CNY 1,972,323,380.43 from CNY 1,967,035,474.47, a growth of approximately 0.27%[19] Shareholder Information - The total number of common shareholders at the end of the reporting period is 30,255[12] - The top three shareholders hold significant stakes: Jiang Chunhua at 9.92% (59,527,137 shares), Luo Xinwei at 9.60% (57,609,416 shares), and Chen Xianlong at 6.24% (37,427,000 shares)[12] - There are no significant changes in the top 10 shareholders due to share lending or borrowing activities[12] Operational Metrics - Operating costs decreased to CNY 109,762,114.22 from CNY 111,235,527.22, showing a reduction of about 1.32%[20] - Research and development expenses rose to CNY 20,976,342.21 from CNY 18,612,616.33, reflecting an increase of about 12.7%[20] - The company's cash and cash equivalents decreased by 41.91% to CNY 436,299,594.95, primarily due to repayment of short-term loans and increased procurement payments[7] - The company's short-term borrowings decreased by 68.22% to CNY 36,000,000.00, reflecting repayment of bank loans[8] - The company's investment income decreased by 84.39% compared to the previous year, attributed to losses from associated companies[9] - The company reported a 98.18% decrease in non-operating income, primarily due to reduced government subsidies received[9] - Accounts receivable slightly decreased to approximately ¥952.13 million from ¥956.12 million, a reduction of about 0.4%[17] - Inventory increased significantly to approximately ¥516.74 million from ¥266.40 million, representing a growth of about 94%[17] - The total number of restricted shares at the end of the period is 116,201,102, down from 142,672,202 at the beginning of the period, indicating a reduction of about 18.5%[15] Strategic Developments - The company has not reported any new product developments or technological advancements in this quarter[14] - There are no significant changes in the top 10 shareholders due to share lending or borrowing activities[12] - The company has not disclosed any plans for market expansion or mergers and acquisitions in this report[14]